PPT Slide

Ligand’s Pacesetting R&D Productivity

$358 Million

Research

$293 Million

Development

(1)1989-2001 including acquired R&D: Glycomed, ALRT, Seragen, and Morphelan?

Cumulative Expenditures (1)

Previous slide

Next slide

Back to first slide

View graphic version